The implementation of the hs-cTnI assay increased the proportion of AMI diagnosis significantly by approximately 10% in patients presenting at the CCU with suspected acute coronary syndrome, and this was similar for women and men. This evidence concerns the gene TNNI3 and acute coronary syndrome.